Home › Targets › CD123

CD123 (2 companies · 2 programs)

Companies with an active program directed at CD123.

Aptevo Therapeutics Inc. APVO

mipletamig — Acute Myeloid Leukemia Phase 1

IN8BIO, INC. INAB

INB-300 Preclinical